MULTICENTRIC RETICULOHISTIOCYTOSIS IN A PATIENT WITH MALIGNANT MELANOMA: A RESPONSE TO CYCLOPHOSPHAMIDE AND A UNIQUE CUTANEOUS FEATURE
- 1 July 1990
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 33 (7) , 1047-1051
- https://doi.org/10.1002/art.1780330720
Abstract
We describe a patient with multicentric reticulohistiocytosis and a history of malignant melanoma. His widely disseminated disease did not affect the site of surgical removal of the malignant melanoma nor the donor site of a skin graft. The multicentric reticulohistiocytosis progressed while the patient was taking nonsteroidal antiinflammatory agents, but showed significant response during a 10‐month course of cyclophosphamide. While he was taking the cyclophosphamide, however, his melanoma recurred, and the patient subsequently died.This publication has 16 references indexed in Scilit:
- Multicentric reticulohistiocytosis: A cause of dysphagia with response to corticosteroidsArthritis & Rheumatism, 1985
- Multicentric reticulohistiocytosis associated with primary biliary cirrhosis: successful treatment with cytotoxic agentsArthritis & Rheumatism, 1984
- Topical nitrogen mustard therapy in multicentric reticulohistiocytosisJournal of the American Academy of Dermatology, 1982
- Multicentric reticulohistiocytosis. Electron microscopic and ultracytochemical studiesArchives of Dermatology, 1981
- Multicentric reticulohistiocytosis and malignant diseaseBritish Journal of Dermatology, 1978
- Reticulohistiocytosis. Remission after cyclophosphamide therapyArthritis & Rheumatism, 1972
- Multicentric reticulohistiocytosis (lipoid dermatoarthritis)The American Journal of Medicine, 1972
- MULTICENTRIC RETICULOHISTIOCYTOSISMedicine, 1969
- A Study of Multicentric ReticulohistiocytosisArchives of Dermatology, 1964